Hims & Hers Health, Inc.

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

HIMS$22.94-11.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In Thousands, Except Share and Per Share Data)

	September 30, 2026	December 31, 2025
(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$605,604	$228,616
Short-term available-for-sale investments	106,617	348,876
Receivables, net	427,847	32,149
Inventory	107,848	80,128
Prepaid expenses and other current assets	73,186	77,869
Total current assets	1,321,102	767,638
Long-term available-for-sale investments	—	351,263
Goodwill	1,110,684	278,325
Property, equipment, and software, net	391,079	311,930
Intangible assets, net	397,261	196,116
Operating lease right-of-use assets	176,861	137,046
Deferred tax assets, net	121,118	82,707
Other long-term assets	28,757	29,680
Total assets	$3,546,862	$2,154,705
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$515,690	$143,278
Accrued liabilities	200,100	77,039
Deferred revenue	144,074	127,160
Deferred acquisition payable	478,595	1,479
Earn-out consideration	86,638	50,632
Operating lease liabilities	10,850	4,843
Total current liabilities	1,435,947	404,431
Convertible senior notes, net	1,367,393	972,580
Operating lease liabilities	182,513	143,167
Deferred acquisition payable	84,503	5,484
Earn-out consideration	84,128	53,009
Deferred tax liabilities, net	27,961	28,856
Other long-term liabilities	9,120	6,250
Total liabilities	3,191,565	1,613,777
Commitments and contingencies (Note 14)
Stockholders' equity:
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 226,020,475 and 218,867,898 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of September 30, 2026 and December 31, 2025	23	23
Additional paid-in capital	711,250	652,383
Accumulated other comprehensive (loss) income	(30,759)	2,294
Accumulated deficit	(325,217)	(113,772)
Total stockholders' equity	355,297	540,928
Total liabilities and stockholders' equity	$3,546,862	$2,154,705

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.